The store will not work correctly when cookies are disabled.
ethyl 6-oxo-4,5,6,11-tetrahydro-1H-pyrrolo[2',3':5,6]azepino[4,3-b]indole-2-carboxylate
ID: ALA5270989
Max Phase: Preclinical
Molecular Formula: C17H15N3O3
Molecular Weight: 309.33
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cc2c([nH]1)-c1[nH]c3ccccc3c1C(=O)NC2
Standard InChI: InChI=1S/C17H15N3O3/c1-2-23-17(22)12-7-9-8-18-16(21)13-10-5-3-4-6-11(10)19-15(13)14(9)20-12/h3-7,19-20H,2,8H2,1H3,(H,18,21)
Standard InChI Key: VRDTYGBQEWABDM-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
-3.5716 0.3559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8570 0.7682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1451 0.3563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1451 -0.4688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8552 -0.8806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5716 -0.4725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3604 -0.7238 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3603 0.6112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8754 -0.0562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0514 -0.0926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4841 0.5338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3439 1.3394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3817 1.7256 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1402 1.4007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3788 -0.7956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2455 0.2180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1803 -0.6036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7237 1.9842 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7638 -1.1871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5609 -0.9735 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5502 -1.9842 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7745 -0.1764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5716 0.0370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
3 8 1 0
8 9 2 0
9 7 1 0
9 10 1 0
10 11 2 0
12 11 1 0
13 12 1 0
14 13 1 0
8 14 1 0
10 15 1 0
11 16 1 0
16 17 2 0
17 15 1 0
14 18 2 0
17 19 1 0
19 20 1 0
19 21 2 0
20 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 309.33 | Molecular Weight (Monoisotopic): 309.1113 | AlogP: 2.58 | #Rotatable Bonds: 2 |
Polar Surface Area: 86.98 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.42 | CX Basic pKa: ┄ | CX LogP: 1.74 | CX LogD: 1.74 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.64 | Np Likeness Score: -0.01 |
References
1. Akunuri R, Vadakattu M, Bujji S, Veerareddy V, Madhavi YV, Nanduri S.. (2021) Fused-azepinones: Emerging scaffolds of medicinal importance., 220 [PMID:33901899] [10.1016/j.ejmech.2021.113445] |